BARRATT JOHN P 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Mar 10, 2010
Insider Transaction Report
Form 4
BARRATT JOHN P
Director
Transactions
- Disposition to Issuer
Common Stock Purchase Option (right to buy)
2009-10-20−35,714→ 0 totalExercise: $0.00Exp: 2010-04-04→ Common Stock (35,714 underlying) - Disposition to Issuer
Common Stock Purchase Option (right to buy)
2009-10-20−70,000→ 0 totalExercise: $0.94Exp: 2009-10-26→ Common Stock (70,000 underlying) - Award
Common Stock Purchase Option (right to buy)
2009-10-20+35,714→ 35,714 totalExercise: $0.00Exp: 2014-10-26→ Common Stock (35,714 underlying) - Disposition to Issuer
Common Stock Purchase Option (right to buy)
2009-10-20−100,000→ 0 totalExercise: $0.56Exp: 2010-04-04→ Common Stock (100,000 underlying) - Award
Common Stock Purchase Option (right to buy)
2009-10-20+70,000→ 70,000 totalExercise: $0.94Exp: 2014-10-26→ Common Stock (70,000 underlying) - Award
Common Stock Purchase Option (right to buy)
2009-10-20+100,000→ 100,000 totalExercise: $0.56Exp: 2014-10-26→ Common Stock (100,000 underlying) - Award
Common Stock Purchase Option (right to buy)
2010-03-08+100,000→ 100,000 totalExercise: $0.64Exp: 2020-03-07→ Common Stock (100,000 underlying)
Footnotes (5)
- [F1]Deemed cancellation of option in connection with deemed grant of replacement option.
- [F2]The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on October 26, 2004. The original terms of vesting were not amended.
- [F3]The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended.
- [F4]The reported transaction involved the extension of the term of an existing option through October 26, 2014. The option was originally granted on April 5, 2005. The original terms of vesting were not amended.
- [F5]This option becomes exercisable in three installments, with the first installment (33,333 shares) exercisable as of the date of grant, the second installment (33,3333 shares) exercisable as of August 1, 2010 and the third installment (33,334 shares) exercisable as of August 1, 2011.